NEVVI Medicare utilization intelligence

← back

ARCE-LARA, CARLOSM.D. NPI 1326265273 Clinician

Hematology-Oncology · CASA GRANDE, AZ

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 27 years since medical school (class of 1999, self-reported to CMS)
Location CASA GRANDE, AZ · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 57 codes billed · 78,881 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
AMERICAN ONCOLOGY PARTNERS PA
2022–2026
ALLIANCE ONCOLOGY OF ARIZONA, LLC
2019–2021

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-08

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0185 Injection, aprepitant, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J0897 Injection, denosumab, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
J2469 Injection, palonosetron hcl, 25 mcg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9395 Injection, fulvestrant, 25 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
J9190 Injection, fluorouracil, 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
J2919 Injection, methylprednisolone sodium succinate, 5 mg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96523 Irrigation of implanted venous access drug delivery device
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
96375 Injection of additional new drug or substance into vein
96415 Administration of chemotherapy into vein, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
96411 Administration of additional new drug or substance into vein using push technique
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
J3490 Unclassified drugs
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
81002 Urinalysis, manual test
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96361 Infusion into a vein for hydration, each additional hour
96360 Infusion into a vein for hydration, 31-60 minutes
99195 Drawing of blood for a medical problem
85610 Blood test, clotting time
96374 Injection of drug or substance into vein
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
38222 Biopsy and aspiration of bone marrow sample for diagnosis
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.